David Kershenobich
Mexico City, DIF, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Individual patient data meta-analysis and systematic review evaluating camostat mesilate to treat COVID-19.
Journal: Journal of clinical and translational science
Published: December 09, 2025
Cost-effectiveness and economic investment to eliminate chronic hepatitis C in Mexico.
Journal: Journal of viral hepatitis
Published: December 24, 2022
Probability of hospitalisation and death among COVID-19 patients with comorbidity during outbreaks occurring in Mexico City.
Journal: Journal of global health
Published: November 07, 2022
Hepatitis C screening and detection program in a large population: Epidemiological transition and characterization of the disease.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: September 28, 2022
Liver transplantation is beneficial regardless of cirrhosis stage or acute-on-chronic liver failure grade: A single-center experience.
Journal: World journal of gastroenterology
Published: April 25, 2022
Outcomes in Temporary ICUs Versus Conventional ICUs: An Observational Cohort of Mechanically Ventilated Patients With COVID-19-Induced Acute Respiratory Distress Syndrome.
Journal: Critical care explorations
Published: April 04, 2022
Prevalence of hepatitis C in the adult Mexican population: National Survey of Health and Nutrition 2018.
Journal: Lancet regional health. Americas
Published: December 31, 2021
Galectin-3 is overexpressed in advanced cirrhosis and predicts post-liver transplant infectious complications.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: November 08, 2021
Last Updated: 09/26/2026